BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 25022583)

  • 1. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.
    Cannatelli A; Giani T; D'Andrea MM; Di Pilato V; Arena F; Conte V; Tryfinopoulou K; Vatopoulos A; Rossolini GM;
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5696-703. PubMed ID: 25022583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
    Cannatelli A; D'Andrea MM; Giani T; Di Pilato V; Arena F; Ambretti S; Gaibani P; Rossolini GM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5521-6. PubMed ID: 23979739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Giordano C; Barnini S; Tsioutis C; Chlebowicz MA; Scoulica EV; Gikas A; Rossen JW; Friedrich AW; Bathoorn E
    Int J Antimicrob Agents; 2018 Feb; 51(2):260-265. PubMed ID: 29097338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
    Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.
    Cannatelli A; Di Pilato V; Giani T; Arena F; Ambretti S; Gaibani P; D'Andrea MM; Rossolini GM
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4399-403. PubMed ID: 24841267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
    Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
    J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
    Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
    J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia.
    Rubic Z; Jelic M; Soprek S; Tarabene M; Ujevic J; Goic-Barisic I; Novak A; Radic M; Tambic Andrasevic A; Tonkic M
    Int Microbiol; 2023 Aug; 26(3):631-637. PubMed ID: 36683114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
    Bonura C; Giuffrè M; Aleo A; Fasciana T; Di Bernardo F; Stampone T; Giammanco A; ; Palma DM; Mammina C
    PLoS One; 2015; 10(7):e0132936. PubMed ID: 26177547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India.
    Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R
    Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
    Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Amino Acid Substitution W20S in MgrB Involved in Polymyxin Resistance in Klebsiella pneumoniae.
    Roch M; Martins WMBS; Sierra R; Gales AC; Andrey DO
    Microbiol Spectr; 2022 Feb; 10(1):e0176621. PubMed ID: 35171013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
    Clancy CJ; Chen L; Hong JH; Cheng S; Hao B; Shields RK; Farrell AN; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5258-65. PubMed ID: 23939888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
    Zhu Y; Galani I; Karaiskos I; Lu J; Aye SM; Huang J; Yu HH; Velkov T; Giamarellou H; Li J
    J Infect; 2019 Oct; 79(4):312-321. PubMed ID: 31374222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae.
    Leung LM; Cooper VS; Rasko DA; Guo Q; Pacey MP; McElheny CL; Mettus RT; Yoon SH; Goodlett DR; Ernst RK; Doi Y
    J Antimicrob Chemother; 2017 Nov; 72(11):3035-3042. PubMed ID: 28961916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
    Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Level Resistance to Colistin Mediated by Various Mutations in the
    Jayol A; Nordmann P; Brink A; Villegas MV; Dubois V; Poirel L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin-resistant KPC-2-producing Klebsiella pneumoniae ST423 harboring an IS5-like element in the mgrB gene isolated from cerebrospinal fluid.
    da Silva HRF; Vilela MA; Almeida ACS; de Morais MMC
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):184-185. PubMed ID: 29540262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.